Altoida, Inc.
About
Altoida, Inc. is a health technology company based in Washington, D.C. that focuses on precision neurology. The company has developed the Digital NeuroMarker Platform, which is FDA-cleared and CE Mark-approved. This platform utilizes AI and augmented reality to enable early detection of cognitive decline, such as Alzheimer's disease, with high accuracy. It is designed for both in-clinic and remote use, providing a quick, self-administered assessment that captures various data points to analyze cognitive function. Altoida's platform is supported by extensive scientific research and clinical trials, making it a valuable tool for assessing brain health. It includes the Altoida Neuro Motor Index, which evaluates daily living activities to classify mild cognitive impairment risk. The platform is used by global pharmaceutical companies for clinical trials and is implemented in clinics across multiple countries, enhancing the diagnostic process in primary care settings.